Poliomyelitis and the role of risk analysis in global infectious disease policy and management

Risk Analysis

Volumn 26, Issue 6, 2006, Pages 1419-1421

  Thompson, Kimberly M ^a,b  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

COST EFFECTIVENESS ANALYSIS; EDITORIAL; ENDEMIC DISEASE; HEALTH CARE ORGANIZATION; HEALTH CARE POLICY; HUMAN; IMMUNIZATION; INFECTION PREVENTION; POLIOMYELITIS; POLITICS; PUBLICATION; RISK ASSESSMENT;

HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; POLIOMYELITIS; POLIOVIRUS; POLIOVIRUS VACCINES; PUBLIC HEALTH; RISK; RISK ASSESSMENT; WORLD HEALTH ORGANIZATION;

EID: 33845675872     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2006.00853.x     Document Type: Editorial

References (19)

1. Kew, O. M., Wright, P. F., Agol, V. I., Delpeyroux, F., Shimizou, H., Nathanson, N., & Pallansch, M. (2004). Circulating vaccine-derived polioviruses: current state of knowledge. WHO Bull, 82, 16-23.
2. Aylward, R. B., Sutter, R. W., & Heymann, D. L. (2005). OPV cessation - The final step to a "polio-free" world. Science, 310, 625-626.
3. Arita, I., Nakane, M., & Fenner, F. (2006). Is polio eradication realistic? Science, 312, 852-854.
4. Roberts, L. (2006). Polio eradication: Is it time to give up? Science, 312, 832-835.
5. Cello, J., Paul, A. V., & Wimmer, E. (2002). Chemical synthesis of poliovirus cDNA: Generation of infectious virus in the absence of natural template. Science, 297, 1016-1018.
6. Henderson, D. A. (2002). Countering the post eradication threat of smallpox and polio. Clinical Infectious Diseases, 34, 79-83.
7. MMWR. (2005). Poliovirus infections in four unvaccinated children - Minnesota, August-October 2005. MMWR Weekly, 54(41), 1053-1055.
8. Sangrujee, N. K., Duintjer Tebbens, R. J., Cáceres, V. M., & Thompson, K. M. (2003). Policy decision options during the first five years following certification of polio eradication. Medscape General Medicine, 5(4). (Available at: http://www.medscape.com/viewarticle/464841.)
9. Thompson, K. M., & Duinter Tebbens, R. J. (2006). Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Analysis, 26(6), 1423-1440.
10. Aylward, R. B., Sutter, R. W., Cochi, S. L., Thompson, K. M., Jafari, H., & Heymann, D. (2006). Risk management in a poliofree world. Risk Analysis, 26(6), 1441-1448.
11. Dowdle, W. R., Van der Avoort, H., de Gourville, E., Delpeyroux, F., Desphande, J., Hovi, T., Martin, J., Pallansch, M. A., Kew, O. M., & Wolff, C. (2006). Containment of polioviruses after eradication and OPV cessation: Characterizing risks to improve management. Risk Analysis, 26(6), 1449-1469.
12. Duintjer Tebbens, R. J., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H., Cochi, S. L., Sutter, R. W., Aylward, R. B., & Thompson, K. M. (2006). Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Analysis, 26(6), 1471-1505.
13. Duinter Tebbens, R. J., Sangrujee, N., & Thompson, K. M. (2006). The costs of future polio risk management policies. Risk Analysis, 26(6), 1507-1531.
14. Fine, P. E. M., & Ritchie, S. (2006). Perspective: Determinants of the severity of poliovirus outbreaks in the post eradication era. Risk Analysis, 26(6), 1533-1540.
15. Thompson, K. M., Duinter Tebbens, R. J., & Pallansch, M. A. (2006). Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Analysis, 26(6), 1541-1556.
16. Duintjer Tebbens, R. J., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Sutter, R. W., & Thompson, K. M. (2005). A dynamic model of poliomyelitis outbreaks: Learning from the past to help inform the future. American Journal of Epidemiology, 162(4), 358-372.
17. GPEI. (2005). Polio News, 25. (Available at http://www.polioeradication. org/content/polionews/PolioNews25.pdf.)
18. de Gourville, E., Duinter Tebbens, R. J., Sangrujee, N., Pallansch, M. A., & Thompson, K. M. (2006). Global surveillance and the value of information: The case of the global polio laboratory network. Risk Analysis, 26(6), 1557-1569.
19. Thompson, K. M., Duinter Tebbens, R. J., Pallansch, M. A., Kew, O. M., Sutter, R. W., Aylward, R. B., Watkins, M., Gary, H., Alexander, J., Venczel, L., Johnson, D., Cáceres, V. M., Sangrujee, N., Jafari, H., & Cochi, S. L. (2006). Perspective: Development and consideration of global policies for managing the future risks of poliovirus outbreaks: Insights and lessons learned through modeling. Risk Analysis, 26(6), 1571-1580.